Non-myeloablative allogeneic stem cell transplantation (NST) for metastatic melanoma: nondurable chemotherapy responses without clinically meaningful graft-vs-tumor (GVT) effects.

R Childs, K Bradstock, D Gottlieb, D Blaise, E Leifer, N Geller, M Mohty, C Faucher, R Srinivasan, R Kefford, U Hegenbart, D Niederwieser, AJ Barrett

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Article number1661
Pages (from-to)429A-429A
Number of pages1
Issue number11
Publication statusPublished - 16 Nov 2002
Externally publishedYes
Event44th Annual Meeting of the American-Society-of-Hematology - Philadelphia, United States
Duration: 6 Dec 200210 Dec 2002

Cite this